Mendelian Randomization Analysis of Systemic Iron Status and Risk of Different Types of Kidney Disease

Overview

Journal Nutrients

Date 2024 Jul 13

PMID 38999730

Authors

Jiahui Zhou

Wanting Shi

Dongya Wu

Shujie Wang

Xinhui Wang

Junxia Min

Fudi Wang

Affiliations

Soon will be listed here.

Abstract

With rapid increases in incidence, diverse subtypes, and complicated etiologies, kidney disease remains a global public health problem. Iron, as an essential trace element, has pleiotropic effects on renal function and the progression of kidney diseases. A two-sample Mendelian randomization (MR) analysis was implemented to determine the potential causal effects between systemic iron status on different kidney diseases. Systemic iron status was represented by four iron-related biomarkers: serum iron, ferritin, transferrin saturation (TfSat), and total iron binding capacity (TIBC). For systemic iron status, 163,511, 246,139, 131,471, and 135,430 individuals were included in the genome-wide association study (GWAS) of serum iron, ferritin, TfSat, and TIBC, respectively. For kidney diseases, 653,143 individuals (15,658 cases and 637,485 controls), 657,076 individuals (8160 cases and 648,916 controls), and 659,320 individuals (10,404 cases and 648,916 controls) were included for immunoglobulin A nephropathy (IgAN), acute kidney disease (AKD), and chronic kidney disease (CKD), respectively. Our MR results showed that increased serum iron [odds ratio (OR): 1.10; 95% confidence interval (95% CI): 1.04, 1.16; < 0.0042], ferritin (OR: 1.30; 95% CI: 1.14, 1.48; < 0.0042), and TfSat (OR: 1.07; 95% CI: 1.04, 1.11; < 0.0042)] and decreased TIBC (OR: 0.92; 95% CI: 0.88, 0.97; < 0.0042) were associated with elevated IgAN risk. However, no significant associations were found between systemic iron status and AKD or CKD. In our MR study, the genetic evidence supports elevated systemic iron status as a causal effect on IgAN, which suggests a potential protective effect of iron chelation on IgAN patients.

References

Chen J, Li X, Ge C, Min J, Wang F . The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 2022; 29(3):467-480. PMC: 8901678. DOI: 10.1038/s41418-022-00941-0. View

Romagnani P, Remuzzi G, Glassock R, Levin A, Jager K, Tonelli M . Chronic kidney disease. Nat Rev Dis Primers. 2017; 3:17088. DOI: 10.1038/nrdp.2017.88. View

Schatzkin A, Abnet C, Cross A, Gunter M, Pfeiffer R, Gail M . Mendelian randomization: how it can--and cannot--help confirm causal relations between nutrition and cancer. Cancer Prev Res (Phila). 2009; 2(2):104-13. PMC: 3052774. DOI: 10.1158/1940-6207.CAPR-08-0070. View

Kassebaum N . The Global Burden of Anemia. Hematol Oncol Clin North Am. 2016; 30(2):247-308. DOI: 10.1016/j.hoc.2015.11.002. View

van Swelm R, Wetzels J, Swinkels D . The multifaceted role of iron in renal health and disease. Nat Rev Nephrol. 2019; 16(2):77-98. DOI: 10.1038/s41581-019-0197-5. View

Ruggenenti P, Schieppati A, Remuzzi G . Progression, remission, regression of chronic renal diseases. Lancet. 2001; 357(9268):1601-8. DOI: 10.1016/S0140-6736(00)04728-0. View

Nemeth E, Valore E, Territo M, Schiller G, Lichtenstein A, Ganz T . Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2002; 101(7):2461-3. DOI: 10.1182/blood-2002-10-3235. View

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice H, Okpechi I . Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385(9981):1975-82. DOI: 10.1016/S0140-6736(14)61601-9. View

Wang X, Zhou Y, Min J, Wang F . Zooming in and out of ferroptosis in human disease. Front Med. 2023; 17(2):173-206. DOI: 10.1007/s11684-023-0992-z. View

10.

Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N, Thompson J . A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017; 36(11):1783-1802. PMC: 5434863. DOI: 10.1002/sim.7221. View

11.

Tian Z, Li Z, Chu L, Liu Y, He J, Xin Y . Iron metabolism and chronic inflammation in IgA nephropathy. Ren Fail. 2023; 45(1):2195012. PMC: 10075521. DOI: 10.1080/0886022X.2023.2195012. View

12.

Locatelli F, Del Vecchio L, Pozzoni P . The importance of early detection of chronic kidney disease. Nephrol Dial Transplant. 2002; 17 Suppl 11:2-7. DOI: 10.1093/ndt/17.suppl_11.2. View

13.

Mehta R, Cerda J, Burdmann E, Tonelli M, Garcia-Garcia G, Jha V . International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015; 385(9987):2616-43. DOI: 10.1016/S0140-6736(15)60126-X. View

14.

Bell S, Rigas A, Magnusson M, Ferkingstad E, Allara E, Bjornsdottir G . A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis. Commun Biol. 2021; 4(1):156. PMC: 7859200. DOI: 10.1038/s42003-020-01575-z. View

15.

van Raaij S, Van Swelm R, Bouman K, Cliteur M, van den Heuvel M, Pertijs J . Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease. Sci Rep. 2018; 8(1):9353. PMC: 6008459. DOI: 10.1038/s41598-018-27107-8. View

16.

Wang H, Nishiya K, Ito H, Hosokawa T, Hashimoto K, Moriki T . Iron deposition in renal biopsy specimens from patients with kidney diseases. Am J Kidney Dis. 2001; 38(5):1038-44. DOI: 10.1053/ajkd.2001.28593. View

17.

Batchelor E, Kapitsinou P, Pergola P, Kovesdy C, Jalal D . Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment. J Am Soc Nephrol. 2020; 31(3):456-468. PMC: 7062209. DOI: 10.1681/ASN.2019020213. View

18.

Pelkonen P, Swanljung K, Siimes M . Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis. Acta Paediatr Scand. 1986; 75(1):64-8. DOI: 10.1111/j.1651-2227.1986.tb10158.x. View

19.

Ratcliffe L, Thomas W, Glen J, Padhi S, Pordes B, Wonderling D . Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale. Am J Kidney Dis. 2016; 67(4):548-58. DOI: 10.1053/j.ajkd.2015.11.012. View

20.

Coresh J, Astor B, Greene T, Eknoyan G, Levey A . Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002; 41(1):1-12. DOI: 10.1053/ajkd.2003.50007. View